Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 11
September 15 2016
Issue Cover

Table of Contents

BLOOD FLASHBACK

McCuskey RS, McClugage SG Jr, Younker WJ. Microscopy of living bone marrow in situ. Blood. 1971;38(1):87-95.
View Articletitled, McCuskey RS, McClugage SG Jr, Younker WJ. Microscopy of living bone marrow in situ. <em>Blood</em>. 1971;38(1):<span class="related-article">87-95</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
How do stem cells mobilize? Bridging the GAP
Steven M. Devine
View Articletitled, How do stem cells mobilize? Bridging the GAP
INSIDE BLOOD COMMENTARY
New mutations for nodal lymphomas of TFH origin
José Fernández-Piqueras
View Articletitled, New mutations for nodal lymphomas of TFH origin

HOW I TREAT

How I treat hepatitis C virus infection in patients with hematologic malignancies
Clinical Trials & Observations
Harrys A. Torres,George B. McDonald
View Articletitled, How I treat hepatitis C virus infection in patients with hematologic malignancies

CLINICAL TRIALS AND OBSERVATIONS

Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Clinical Trials & Observations
Anita Kumar,Carla Casulo,Joachim Yahalom,Heiko Schöder,Paul M. Barr,Philip Caron,April Chiu,Louis S. Constine,Pamela Drullinsky,Jonathan W. Friedberg,John F. Gerecitano,Audrey Hamilton,Paul A. Hamlin,Steven M. Horwitz,Alexandra G. Jacob,Matthew J. Matasar,Gianna N. McArthur,Susan J. McCall,Alison J. Moskowitz,Ariela Noy,Maria L. Palomba,Carol S. Portlock,David J. Straus,Nicholas VanderEls,Stephanie L. Verwys,Joanna Yang,Anas Younes,Andrew D. Zelenetz,Zhigang Zhang,Craig H. Moskowitz
View Articletitled, Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Phosphoproteomic profiling of mouse primary HSPCs reveals new regulators of HSPC mobilization
Leo D. Wang,Scott B. Ficarro,John N. Hutchinson,Roland Csepanyi-Komi,Phi T. Nguyen,Eva Wisniewski,Jessica Sullivan,Oliver Hofmann,Erzsebet Ligeti,Jarrod A. Marto,Amy J. Wagers
View Articletitled, Phosphoproteomic profiling of mouse primary HSPCs reveals new regulators of HSPC mobilization
Supplemental data

IMMUNOBIOLOGY

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
Yumeng Mao,Vincent van Hoef,Xiaonan Zhang,Erik Wennerberg,Julie Lorent,Kristina Witt,Laia Masvidal,Shuo Liang,Shannon Murray,Ola Larsson,Rolf Kiessling,Andreas Lundqvist
View Articletitled, IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
Supplemental data

LYMPHOID NEOPLASIA

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas
David Vallois,Maria Pamela D. Dobay,Ryan D. Morin,François Lemonnier,Edoardo Missiaglia,Mélanie Juilland,Justyna Iwaszkiewicz,Virginie Fataccioli,Bettina Bisig,Annalisa Roberti,Jasleen Grewal,Julie Bruneau,Bettina Fabiani,Antoine Martin,Christophe Bonnet,Olivier Michielin,Jean-Philippe Jais,Martin Figeac,Olivier A. Bernard,Mauro Delorenzi,Corinne Haioun,Olivier Tournilhac,Margot Thome,Randy D. Gascoyne,Philippe Gaulard,Laurence de Leval
View Articletitled, Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas
Supplemental data

MYELOID NEOPLASIA

CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice
Qi Cai,Robin Jeannet,Wei-Kai Hua,Guerry J. Cook,Bin Zhang,Jing Qi,Hongjun Liu,Ling Li,Ching-Cheng Chen,Guido Marcucci,Ya-Huei Kuo
View Articletitled, CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice
Supplemental data

TRANSPLANTATION

Genetic risk factors for sclerotic graft-versus-host disease
CME
Yoshihiro Inamoto,Paul J. Martin,Mary E. D. Flowers,Stephanie J. Lee,Paul A. Carpenter,Edus H. Warren,Daniel E. Geraghty,Ni Lee,Michael J. Boeckh,Barry E. Storer,David M. Levine,Wenhong Fan,Lue-Ping Zhao,John A. Hansen
View Articletitled, Genetic risk factors for sclerotic graft-versus-host disease
Supplemental data

LETTERS TO BLOOD

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia
Clinical Trials & Observations
Hongming Zhu,Jiong Hu,Li Chen,Wei Zhou,Xiaoyang Li,Lining Wang,Xia Zhao,Yunxiang Zhang,Huijin Zhao,Aihua Wang,Yú Chen,Huiping Sun,Qiusheng Chen,Yù Chen,Weili Zhao,Jianqing Mi,Zhixiang Shen,Zhenyi Wang,Zhu Chen,Saijuan Chen,Junmin Li
View Articletitled, The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia
Supplemental data
Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation
Clinical Trials & Observations
Raffaella Greco,Francesca Lorentino,Mara Morelli,Fabio Giglio,Daniele Mannina,Andrea Assanelli,Sara Mastaglio,Serena Dalto,Tommaso Perini,Lorenzo Lazzari,Simona Piemontese,Consuelo Corti,Magda Marcatti,Massimo Bernardi,Maria Teresa Lupo Stanghellini,Fabio Ciceri,Jacopo Peccatori
View Articletitled, Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation

BLOOD WORK

Marked stress dyspoiesis secondary to sepsis and extracorporeal membrane oxygenation
Jonathan D. Boyd,Arthur W. Zieske
View Articletitled, Marked stress dyspoiesis secondary to sepsis and extracorporeal membrane oxygenation

ERRATA

Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188-195.
View Articletitled, Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. <em>Blood.</em> 2014;124(2):188-195.

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Genetic polymorphisms related to sclerotic GVHD
CME
View Articletitled, Genetic polymorphisms related to sclerotic GVHD
  • Cover Image

    Cover Image

    issue cover

    Ribbon diagram showing the crystal structure of an HLA-DP molecule. The α chain (yellow) and β chain (blue) form a groove that binds the self-peptide (green). Residues highlighted in red form a pocket that binds the side chain of a peptide anchor residue. The structure of this pocket is associated with the risk of sclerosis in patients with chronic graft-versus-host disease. See the article by Inamoto et al on page 1516.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkTable of Contents
  • PDF Icon PDF LinkBack Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals